Please click here to see the latest news stories relating to Covid-19

Bionow members are welcome to submit PR items to this newsroom for all to see. Describing current activity and progress in the sector, it's a great place to promote your organisation and keep up to date with the latest developments.

Whether currently a member or not, also keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

The CY Partners team are celebrating the arrival of four fantastic new team members and I am thrilled to introduce to you the first up: Kieran Martin!

Leading pharmaceutical and biotech product development consultancy, Boyds, has hired regulatory expert in the pharma, biotech and medical devices sectors, Eamonn McGowran as Associate Direct...

We are excited to tell you that Peak Proteins is moving to a new, purpose designed building with new laboratories (and offices) in Tytherington in Macclesfield early next year.

Infex Therapeutics is pressing ahead with a major development of its pandemic resilience strategy by today announcing an agreement with CRUK Newcastle Drug Discovery Unit.

A medical laboratory company recently contacted Aport to project manage the movement of a Covid-19 testing laboratory including all its equipment and instruments into storage.

Researchers have found that saliva samples are just as effective at diagnosing COVID-19 as respiratory swabs that are currently being used.

Atelerix welcomes Steve Docksey as Executive Chair and Ed Wagena as Chief Operating Officer! Atelerix has significantly strengthened its leadership team with two experienced industry execut...

More and more of us are continuing working from our homes, including all the CY team! So how do we manage to remain efficient and not get distracted while working in an environment we usual...

The ability to work from home has been of ever-growing importance to the workforce over the last decade. Flexibility has become a staple of a well-rounded employee value proposition. As we a...

The University of Liverpool, University of Edinburgh and Imperial College London have together received £5 million from the Medical Research Council to tackle the coronavirus pandemic from ...

Biosignatures has raised £3.5m to fund its goal of developing 20 novel diagnostic screening tests.

The £80,000 joint fund has been established to pump-prime up to eight projects that aim to provide solutions to unmet healthcare needs.

Our Valued Sponsors & Partners